Last Updated on November 2, 2021 The Food and Drug Administration approved the “first oral blood thinning medication for children” a few months ahead of their COVID-19 vaccine rollout for children ages 5-11. In late June 2021, the Food and Drug Administration (FDA) approved a drug called Pradaxa; oral pellets to treat children 3 months … Continue reading FDA Approved ‘First Oral Blood Thinning Medication For Children’ Ahead Of Vaccine Rollout For Ages 5-11